RISK FACTORS FOR HYPERSENSITIVITY REACTIONS (HSRS) AMONG OVARIAN CANCER (EOC) PATIENTS TREATED WITH CARBOPLATIN-BASED CHEMOTHERAPY

被引：0
|
作者：
Jerzak, K. [1 ]
Manshadi, S. Deghan [1 ]
Ng, P. [2 ]
Maganti, M. [2 ]
McCuaig, J. M. [2 ]
Oza, A. [2 ]
Mackay, H. [2 ]
机构：
[1] Univ Toronto, Toronto, ON, Canada
[2] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2014年 / 24卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IGCSM-0974
引用
收藏
页码：331 / 332
页数：2
相关论文
共 50 条
  • [1] HYPERSENSITIVITY REACTIONS IN PATIENTS RECEIVING CARBOPLATIN-BASED CHEMOTHERAPY
    Khalil, Said
    Ceccarelli, Francesca
    ANNALS OF ONCOLOGY, 2009, 20
  • [2] Intraperitoneal carboplatin-based chemotherapy for ovarian cancer
    Fujiwara, Keiichi
    Nagao, Shoji
    Goto, Tomoko
    Shimizu, Motohiro
    Iwasa, Norihiro
    CANCER INVESTIGATION, 2007, 25 : 24 - 25
  • [3] The feasibility of carboplatin-based intraperitoneal chemotherapy in ovarian cancer
    Kim, Sang-Wun
    Paek, Jiheum
    Nam, Eun-Ji
    Kim, Sung-Hoon
    Kim, Jae-Hoon
    Kim, Young-Tae
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2010, 152 (02) : 195 - 199
  • [4] Intraperitoneal carboplatin-based chemotherapy for epithelial ovarian cancer
    Fujiwara, K
    Markman, M
    Morgan, M
    Coleman, RL
    GYNECOLOGIC ONCOLOGY, 2005, 97 (01) : 10 - 15
  • [5] Carboplatin-based chemotherapy in elderly patients with newly diagnosed or relapsed epithelial ovarian cancer
    Zamagni, Claudio
    Cacciari, Nicoletta
    Bernardi, Alessandra
    Giaquinta, Stefania
    De Iaco, Pierandrea
    De Aloysio, Domenico
    Peiusi, Giuseppe
    Martoni, Andrea
    ANNALS OF ONCOLOGY, 2004, 15 : 126 - 126
  • [6] Dietary Magnesium Replacement for Prevention of Hypomagnesemia in Patients With Ovarian Cancer Receiving Carboplatin-Based Chemotherapy
    Liu, Wenli
    Meyer, Larissa
    Morse, Meroe
    Li, Yisheng
    Song, Juhee
    Engle, Rosalinda
    Lopez, Gabriel
    Narayanan, Santhosshi
    Soliman, Pamela T.
    Ramondetta, Lois
    Bruera, Eduardo
    Cohen, Lorenzo
    JCO ONCOLOGY PRACTICE, 2024, 20 (04) : 517 - 524
  • [7] Favourable outcome of ovarian germ cell malignancies treated with cisplatin or Carboplatin-based chemotherapy
    Dimopoulos, MA
    Papadopoulou, M
    Andreopoulou, E
    Papadimitriou, C
    Pavlidis, N
    Aravantinos, G
    Asproporamitis, A
    Anagnostopoulos, A
    Fountzilas, G
    Athanassiades, P
    Pectacides, D
    ANNALS OF ONCOLOGY, 1998, 9 : 71 - 71
  • [8] Prognostic impact of the pretherapeutic hemoglobin level for patients with primary ovarian cancer receiving a carboplatin-based chemotherapy
    Eichbaum, M. H. R.
    Weiss, L.
    Bruckner, T.
    Gebauer, G.
    Schneeweiss, A.
    Fersis, N.
    Sohn, C.
    EJC SUPPLEMENTS, 2005, 3 (02): : 269 - 270
  • [9] TOLERABILITY AND ACTIVITY OF CARBOPLATIN-BASED CHEMOTHERAPY IN ELDERLY PATIENTS (AGED 70 AND OVER) WITH EPITHELIAL OVARIAN CANCER
    Cacciari, Nicoletta
    Bernardi, Alessandra
    Zamagni, Claudio
    Giaquinta, Stefania
    Martoni, Andrea
    ANNALS OF ONCOLOGY, 2004, 15 : 93 - 94
  • [10] Risk factors for and prognosis of carboplatin-related hypersensitivity in patients with epithelial ovarian cancer
    Hwang, Woo Yeon
    Lee, Minjung
    Suh, Dong Hoon
    Kim, Kidong
    No, Jae Hong
    Kim, Yong Beom
    Kim, Ju-Hyun
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2022, 306 (02) : 443 - 449
12345